Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus

Chikungunya virus (CHIKV) has emerged as one of the most significant arboviral threats in many parts of the world. In spite of large scale morbidity, and long lasting polyarthralgia, no licensed vaccine or antivirals are available for the clinical management of CHIKV infection. In this study, a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Amrita, Bhagyawant, Sameer S., Parida, Manmohan, Dash, Paban Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113671/
https://www.ncbi.nlm.nih.gov/pubmed/27565991
http://dx.doi.org/10.1016/j.antiviral.2016.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113671/
https://www.ncbi.nlm.nih.gov/pubmed/27565991
http://dx.doi.org/10.1016/j.antiviral.2016.08.019

Ejemplares similares